Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001771:Blood Banks / Q000592:standards*; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000592:standards / Q000627:therapeutic use*; D005169:Factor VIII / Q000592:standards / Q000627:therapeutic use*; D015658:HIV Infections / Q000401:mortality / Q000635:transmission; D015528:HIV Seroprevalence; D006467:Hemophilia A / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D012449:Safety
D005169:Factor VIII; D005164:Factor IX